3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
33
Prostatic Neoplasms
8
Triple Negative Breast Neoplasms
4
Pancreatic Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Renal Cell
3
Uterine Cervical Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pleural Effusion, Malignant
2
Ovarian Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Lymphedema
2
Liver Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Infertility
2
Hodgkin Disease
2
Fibrosis
2
Carcinoma, Medullary
2
Carcinoma, Intraductal, Noninfiltrating
2
Anatomic Stage III Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uterine Hemorrhage
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Thyroid Nodule
1
Thyroid Cancer, Papillary
1
Stomatitis
1
Somatostatinoma
1
Soft Tissue Neoplasms
1
Interventions
Standard of Care
2
tocilizumab
1
Tomography, X-Ray Computed
1
Practice Guidelines as Topic
1
Operative Blood Salvage
1
Molecular Imaging
1
Methods
1
Magnetic Resonance Spectroscopy
1
Interviews as Topic
1
Immunoglobulin G
1
High-Energy Shock Waves
1
Educational Status
1
Early Intervention, Educational
1
Disulfides
1
Cardiac Surgical Procedures
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Coronary Artery Disease
×
High-Energy Shock Waves
×
Clear all
NCT01230905
2017-04-24
AST
Ottawa Heart Institute Research Corporation
Phase 4
Completed
181 enrolled